Oral Fluid Testing: What the New DOT Rule Means for Employers

For decades, regulated employers had effectively one approved way to collect a specimen for federal drug testing: urine. The Department of Transportation has now amended its testing rule under 49 CFR Part 40 to authorize oral fluid as a second, alternative collection method across the DOT-regulated modes. For safety managers and HR leaders running a federal testing program, this is one of the more consequential procedural changes in years — and it deserves a clear-eyed read rather than a rushed rollout.

The headline is straightforward: oral fluid testing is permitted. The reality underneath it is more nuanced. Authorization does not equal availability, the new method does not replace urine, and the choice between the two carries real operational and compliance implications. This article walks through what actually changed, when oral fluid can be used, how the collection differs, and what employers should put in place before adopting it.

What Actually Changed in the Rule

Part 40 governs how all DOT drug and alcohol testing is conducted — the procedures, the chain of custody, the role of the Medical Review Officer, and the standards every collector and laboratory must meet. The amendment adds oral fluid as an authorized specimen type alongside urine, harmonizing DOT procedures with the scientific and technical guidelines published by the Substance Abuse and Mental Health Services Administration (SAMHSA) for federal workplace programs.

Critically, the rule gives employers a choice of methodology rather than a mandate. Urine testing remains fully valid and is not going away. Oral fluid is an option an employer may elect to use, subject to the conditions and limitations the rule sets out. Both methods continue to flow through the same compliance backbone: certified laboratories, a qualified Medical Review Officer to interpret results, and the protections built into Part 40 that exist to keep the process defensible.

Authorization Is Not the Same as Availability

This is the single most important point for any employer eager to adopt oral fluid: the method cannot be used in DOT testing until at least two laboratories are certified by HHS to perform oral fluid analysis. That two-laboratory requirement exists so the program always has a certified facility available for primary testing and a second for split-specimen confirmation, preserving the donor's right to a confirmatory test.

Until that certification threshold is met, oral fluid collections cannot be used for DOT-regulated tests, even though the regulatory text permits them. Employers and their service agents should confirm laboratory certification status before building oral fluid into any policy or scheduling a single collection. Moving early on paper, without confirmed laboratory capacity, simply creates a program that cannot lawfully execute.

How the Collection Process Differs

The most visible difference is at the point of collection. An oral fluid specimen is gathered from inside the donor's mouth using an approved collection device, typically a swab, rather than the private restroom-based process a urine collection requires. This changes the logistics, the facility needs, and the donor experience in several practical ways.

• Directly observed by design — the collector watches the specimen being gathered, which reduces the opportunity for adulteration or substitution without the privacy concerns of an observed urine collection.
• Smaller footprint — oral fluid does not require a secured, water-restricted restroom, which can simplify collections at remote job sites, terminals, and field locations common in oil and gas and transportation work.
• Different detection window — oral fluid generally reflects more recent use, which can make it well suited to post-accident and reasonable-suspicion scenarios where recent impairment is the concern.
• Same chain-of-custody rigor — the specimen still moves under a federal custody-and-control form, to a certified laboratory, and through Medical Review Officer review before any result is reported.

Collectors must be trained and qualified specifically for the oral fluid method; urine certification does not automatically transfer. Any employer planning to offer oral fluid needs to confirm that its collection sites have appropriately trained personnel and approved devices before the first regulated test.

When Each Method Makes Sense

Because both methods are valid, the practical question becomes when to use which. The rule contemplates situations where one specimen type is preferable — for example, when a problem arises with a collection and a different method may be needed to complete the test. Employers should think through these scenarios in advance rather than deciding case by case at the collection site.

Operationally, oral fluid's smaller facility requirements and observed collection can be attractive for dispersed workforces and post-accident testing, where speed and proximity matter. Urine remains the established method with the broadest laboratory infrastructure and a longer detection window for certain substances. The right answer is rarely all of one or the other — it is a deliberate program design that documents which method applies in which circumstance, and trains supervisors and collection sites accordingly.

What Employers Should Do Now

Even before laboratory certification opens oral fluid for live use, there is preparation worth doing. Getting ahead of the operational and policy work means an employer can adopt the method cleanly rather than scrambling once it becomes available.

• Review and update your written drug and alcohol testing policy to reflect that oral fluid may be used, and to define when each method applies.
• Confirm with your laboratories and collection providers whether they are pursuing oral fluid certification and what their timeline looks like.
• Verify that collectors who will perform oral fluid collections are trained and qualified for the method, with approved devices on hand.
• Train supervisors and decision-makers on any differences in how post-accident and reasonable-suspicion testing may be handled.
• Coordinate with your Medical Review Officer so result interpretation and reporting are aligned across both specimen types.

Beyond the DOT context, employers should remember that non-DOT testing — and the broader compliance environment shaped by frameworks such as the FCRA, EEOC guidance, OSHA, and the Drug-Free Workplace Act — continues to operate alongside these federal procedures. A change to one part of a testing program should be checked against the whole.

Bringing It Together

The addition of oral fluid to Part 40 is a meaningful expansion of how regulated employers can meet their federal testing obligations. It introduces flexibility that can genuinely help dispersed, field-based workforces, but it arrives with conditions — laboratory certification, collector qualification, and thoughtful policy updates — that determine whether an employer can use it well or simply on paper.

Keeping a testing program current across evolving DOT procedures, multiple regulatory frameworks, and a workforce spread across sites is precisely the kind of ongoing work that a dedicated compliance partner or third-party administrator is built to absorb — quietly handling the policy updates, collector qualifications, and laboratory coordination so the change becomes a routine improvement rather than another administrative burden.